S&P 500

5.930,85

1,09%

Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Gen Digital Inc (GEN)
Gen Digital Inc (GEN) Notícias

GEN

Gen Digital (GEN)

Gen Digital Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:GEN

1 2 3 4 5 6 7 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
10/12/2024	19:25	PR Newswire (US)	ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of MoneyLion Inc.	NASDAQ:GEN	Gen Digital Inc
10/12/2024	18:08	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:GEN	Gen Digital Inc
10/12/2024	10:11	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GEN	Gen Digital Inc
10/12/2024	10:00	PR Newswire (US)	Gen Extends its Financial Wellness Offerings with the Acquisition of MoneyLion	NASDAQ:GEN	Gen Digital Inc
04/12/2024	11:00	PR Newswire (US)	Gen Reveals Cybersecurity Predictions for 2025	NASDAQ:GEN	Gen Digital Inc
03/12/2024	18:47	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GEN	Gen Digital Inc
26/11/2024	18:15	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:GEN	Gen Digital Inc
21/11/2024	13:30	PR Newswire (US)	Norton Introduces Small Business Premium for Powerful, Easy-to-Use Business-Grade Security	NASDAQ:GEN	Gen Digital Inc
19/11/2024	11:00	PR Newswire (US)	Gen Q3 Threat Report: Millions Fooled by "Scam-Yourself Attacks"	NASDAQ:GEN	Gen Digital Inc
06/11/2024	13:01	GlobeNewswire Inc.	Genmab Announces Financial Results for the First Nine Months of 2024	NASDAQ:GEN	Gen Digital Inc
31/10/2024	18:27	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:GEN	Gen Digital Inc
31/10/2024	17:37	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:GEN	Gen Digital Inc
30/10/2024	17:05	PR Newswire (US)	Gen Reports Second Quarter Fiscal Year 2025 Results	NASDAQ:GEN	Gen Digital Inc
29/10/2024	04:01	PR Newswire (US)	Don't Let Scammers Steal Your Holiday Cheer: New Norton Report Reveals Nearly Half of U.S. Consumers Were Targeted by a Scam While Online Shopping	NASDAQ:GEN	Gen Digital Inc
17/10/2024	17:00	PR Newswire (US)	Election Scams on the Rise: Over Half of Americans Targeted with Election Scams	NASDAQ:GEN	Gen Digital Inc
15/10/2024	07:25	GlobeNewswire Inc.	Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2024	NASDAQ:GEN	Gen Digital Inc
08/10/2024	17:05	PR Newswire (US)	Gen to Announce Fiscal 2025 Second Quarter Results on October 30, 2024	NASDAQ:GEN	Gen Digital Inc
04/10/2024	14:55	GlobeNewswire Inc.	Major Shareholder Announcement	NASDAQ:GEN	Gen Digital Inc
24/09/2024	12:00	PR Newswire (US)	Norton Benefit Solutions Expands Global Offering	NASDAQ:GEN	Gen Digital Inc
19/09/2024	09:00	PR Newswire (US)	AARP Services Announces New Enhanced Offerings for AARP Members This Fall	NASDAQ:GEN	Gen Digital Inc
13/09/2024	17:15	Edgar (US Regulatory)	Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]	NASDAQ:GEN	Gen Digital Inc
04/09/2024	10:00	PR Newswire (US)	Multi-million-dollar Deepfake Campaigns Blocked by Gen	NASDAQ:GEN	Gen Digital Inc
21/08/2024	10:00	PR Newswire (US)	Parents Cautiously Optimistic on AI in Schools: Content Safety and Data Privacy Among Top Worries	NASDAQ:GEN	Gen Digital Inc
19/08/2024	15:00	GlobeNewswire Inc.	TEPKINLY® (epcoritamab) Receives Second European Commission Approval for the Treatment of Adults with Relapsed/Refractory Follicular Lymphoma	NASDAQ:GEN	Gen Digital Inc
08/08/2024	12:03	GlobeNewswire Inc.	Genmab Announces Financial Results for the First Half of 2024	NASDAQ:GEN	Gen Digital Inc
08/08/2024	12:00	GlobeNewswire Inc.	Genmab Updates 2024 Financial Guidance	NASDAQ:GEN	Gen Digital Inc
06/08/2024	10:00	PR Newswire (US)	New LifeLock Scan Tool Reveals Our Data is 'Out of Control'	NASDAQ:GEN	Gen Digital Inc
05/08/2024	06:50	GlobeNewswire Inc.	Genmab Takes Full Control of Acasunlimab Development Program	NASDAQ:GEN	Gen Digital Inc
01/08/2024	17:05	PR Newswire (US)	Gen Reports First Quarter Fiscal Year 2025 Results	NASDAQ:GEN	Gen Digital Inc
30/07/2024	13:00	PR Newswire (US)	New Norton VPN Lineup Delivers Ultra Protection	NASDAQ:GEN	Gen Digital Inc